tiprankstipranks
Heron Therapeutics (HRTX)
NASDAQ:HRTX
US Market

Heron Therapeutics (HRTX) Technical Analysis

Compare
1,554 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Heron Therapeutics’s (HRTX) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Heron Therapeutics is a Buy.
Heron Therapeutics’s (HRTX) 20-Day exponential moving average is 1.71, while Heron Therapeutics’s (HRTX) share price is $1.73, making it a Buy.
Heron Therapeutics’s (HRTX) 50-Day exponential moving average is 1.67, while Heron Therapeutics’s (HRTX) share price is $1.73, making it a Buy.

Heron Therapeutics (HRTX) Pivot Points

Feb 22, 2025, 03:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.63
1.65
1.69
1.71
1.75
1.77
1.81
Fibonacci
1.65
1.68
1.69
1.71
1.74
1.75
1.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Heron Therapeutics (HRTX) Moving Averages

Feb 22, 2025, 03:37 AM
Period
Simple
Exponential
MA5
1.73Buy
1.72Buy
MA10
1.70Buy
1.72Buy
MA20
1.73Sell
1.71Buy
MA50
1.66Buy
1.67Buy
MA100
1.65Buy
1.75Sell
MA200
2.20Sell
2.15Sell
Heron Therapeutics’s (HRTX) 10-Day exponential moving average is 1.72, while Heron Therapeutics’s (HRTX) share price is $1.73, making it a Buy.
Heron Therapeutics’s (HRTX) 100-Day exponential moving average is 1.75, while Heron Therapeutics’s (HRTX) share price is $1.73, making it a Sell.
Heron Therapeutics’s (HRTX) stock price is $1.73 and Heron Therapeutics’s (HRTX) 50-day simple moving average is 1.66, creating a Buy signal.
Heron Therapeutics’s (HRTX) stock price is $1.73 and Heron Therapeutics’s (HRTX) 100-day simple moving average is 1.65, creating a Buy signal.
Heron Therapeutics’s (HRTX) stock price is $1.73 and Heron Therapeutics’s (HRTX) 200-day simple moving average is 2.20, creating a Sell signal.

Heron Therapeutics (HRTX) Technical Indicators

Feb 22, 2025, 03:37 AM
Name
Value
Implied Action
RSI (14)
52.85
Neutral
STOCH (9,6)
45.94
Neutral
STOCHRSI (14)
36.68
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
17.54
Buy
Williams %R
-57.93
Buy
CCI (14)
-4.31
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
50.26
Neutral
ROC
1.76
Buy
Heron Therapeutics’s (HRTX) Relative Strength Index (RSI) is 52.85, creating a Neutral signal.
Heron Therapeutics’s (HRTX) Trend Strength Indicator (ADX) is 17.54, creating a Buy signal.
Heron Therapeutics’s (HRTX) Commodity Channel Index (CCI) is -4.31, creating a Neutral signal.
Heron Therapeutics’s (HRTX) Price Rate of Change (ROC) is 1.76, creating a Buy signal.

FAQ

Is HRTX a Buy, Hold, or Sell?
Based on HRTX’s technical indicators, HRTX is a Buy.
    What is HRTX’s RSI (14)?
    HRTX’s RSI (14) is 52.85, which suggests HRTX is a Neutral.
      What is HRTX’s MACD?
      HRTX’s MACD is 0.02, which suggests HRTX is a Buy.
        What is HRTX’s 5-day moving average?
        HRTX’s 5-day moving average is 1.73, which suggests HRTX is a Buy.
          What is HRTX’s 20-day moving average?
          HRTX 20-day moving average is 1.73, which suggests HRTX is a Sell.
            What is HRTX’s 50-day moving average?
            HRTX’s 50-day moving average is 1.66, which suggests HRTX is a Buy.
              What is HRTX’s 200-day moving average?
              HRTX’s 200-day moving average is 2.20, which suggests HRTX is a Sell.
                What is HRTX’s Williams % R (14)?
                HRTX’s Williams % R (14) is -57.93, which suggests HRTX is a Buy.
                  What is HRTX’s CCI (14)?
                  HRTX’s CCI (14) is -4.31, which suggests HRTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis